KDM4B and neoplasm: The small molecule KDM4B inhibitor B3 sensitized C-R PC cells and C-R PC xenografts to enzalutamide (nonsteroidal AR inhibitor), and synergistically blocked tumor growth in combination with rapamycin [186].